Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Multimodal Imaging Assessment of the Inflammatory Atheromatous Plaque — Stella

Home/Inflammation/Multimodal Imaging Assessment of the Inflammatory Atheromatous Plaque

View on ClinicalTrials.gov

Recruiting

Back to Inflammation trials

Multimodal Imaging Assessment of the Inflammatory Atheromatous Plaque

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Switzerland

Centre Hospitalier Universitaire Vaudois, Lausanne, Canton of Vaud

Key details

Phase

Early testing / Safety & dosing

Sponsor

University of Lausanne Hospitals

Collaborators

Swiss Heart Foundation

Enrollment target

~20 participants

Started

April 2012

Primary completion

December 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 85 Years

Last updated June 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.